Search Results - "Woodruff, T.M"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Elevation of the terminal complement activation products C5a and C5b-9 in ALS patient blood by Mantovani, S, Gordon, R, Macmaw, J.K, Pfluger, C.M.M, Henderson, R.D, Noakes, P.G, McCombe, P.A, Woodruff, T.M

    Published in Journal of neuroimmunology (15-11-2014)
    “…Abstract Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease, characterized by the progressive loss of motor neurons within the central…”
    Get full text
    Journal Article
  2. 2

    Altered expression of metabolic proteins and adipokines in patients with amyotrophic lateral sclerosis by Ngo, S.T, Steyn, F.J, Huang, L, Mantovani, S, Pfluger, C.M.M, Woodruff, T.M, O'Sullivan, J.D, Henderson, R.D, McCombe, P.A

    Published in Journal of the neurological sciences (15-10-2015)
    “…Abstract Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disease characterized by the loss of upper cortical and lower motor neurons…”
    Get full text
    Journal Article
  3. 3

    Neuroprotection in stroke by complement inhibition and immunoglobulin therapy by Arumugam, T.V, Woodruff, T.M, Lathia, J.D, Selvaraj, P.K, Mattson, M.P, Taylor, S.M

    Published in Neuroscience (06-02-2009)
    “…Abstract Activation of the complement system occurs in a variety of neuroinflammatory diseases and neurodegenerative processes of the CNS. Studies in the last…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Monocyte CD14 and HLA-DR expression increases with disease duration and severity in amyotrophic lateral sclerosis by Mcgill, R.B., Steyn, F.J., Ngo, S.T., Thorpe, K.A., Heggie, S., Henderson, R.D., Mccombe, P.A., Woodruff, T.M.

    “…Objective: To investigate changes in immune markers and frequencies throughout disease progression in patients with amyotrophic lateral sclerosis (ALS)…”
    Get full text
    Journal Article
  6. 6

    Staphylococcus aureus‐induced complement activation promotes tissue factor‐mediated coagulation by Skjeflo, E. W., Christiansen, D., Fure, H., Ludviksen, J. K., Woodruff, T. M., Espevik, T., Nielsen, E. W., Brekke, O. L., Mollnes, T. E.

    Published in Journal of thrombosis and haemostasis (01-05-2018)
    “…Essentials Complement, Toll‐like receptors and coagulation cross‐talk in the process of thromboinflammation. This is explored in a unique human whole‐blood…”
    Get full text
    Journal Article
  7. 7

    Phagocytosis of live and dead Escherichia coli and Staphylococcus aureus in human whole blood is markedly reduced by combined inhibition of C5aR1 and CD14 by Skjeflo, E.W., Christiansen, D., Landsem, A., Stenvik, J., Woodruff, T.M., Espevik, T., Nielsen, E.W., Mollnes, T.E.

    Published in Molecular immunology (01-08-2019)
    “…•Blocking C5aR1 and CD14 reduced phagocytosis and cytokine release in response to S. aureus and E. coli over time in blood.•The effect ofPMX-53 was potentiated…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13